Patents by Inventor Ellen Schmidt

Ellen Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10660878
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: May 26, 2020
    Assignee: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Publication number: 20180071254
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Application
    Filed: September 6, 2017
    Publication date: March 15, 2018
    Inventors: Ellen SCHMIDT, Johan AREBERG
  • Patent number: 9789085
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: October 17, 2017
    Assignee: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Patent number: 9687473
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: June 27, 2017
    Assignee: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Patent number: 9642837
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: May 9, 2017
    Assignee: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Publication number: 20160354343
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Application
    Filed: June 28, 2016
    Publication date: December 8, 2016
    Inventors: Ellen SCHMIDT, Johan AREBERG
  • Publication number: 20160256437
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-lH-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Application
    Filed: March 30, 2016
    Publication date: September 8, 2016
    Inventors: Ellen SCHMIDT, Johan AREBERG
  • Patent number: 9427775
    Abstract: The present invention provides a process for imparting a simulated patina, or antique appearance to a substrate by using a coating composition comprising a perlite based effect pigment. The perlite based effect pigment functions as colorant and matting agent and shows an almost angle independent brightness. The process provides, for example, decorative wall coatings showing enhanced antique, or patina effects as compared to conventional effect pigments on basis of mica.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: August 30, 2016
    Assignee: BASF SE
    Inventors: Raimund Schmid, Ellen Schmidt
  • Patent number: 9375418
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: June 28, 2016
    Assignee: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Publication number: 20140073681
    Abstract: The present invention describes methods of treating dementia comprising administering an effective daily dose of N-(2-(6-fluoro-1H-indol-3-yl)ethyl-(2,2,3,3-tetrafluoropropoxy)benzylamine to improve or augment the effect of an acetylcholinesterase inhibitor.
    Type: Application
    Filed: September 9, 2013
    Publication date: March 13, 2014
    Applicant: H. LUNDBECK A/S
    Inventors: Ellen Schmidt, Johan Areberg
  • Publication number: 20120027993
    Abstract: The present invention provides a process for imparting a simulated patina, or antique appearance to a substrate by using a coating composition comprising a perlite based effect pigment. The perlite based effect pigment functions as colorant and matting agent and shows an almost angle independent brightness. The process provides, for example, decorative wall coatings showing enhanced antique, or patina effects as compared to conventional effect pigments on basis of mica.
    Type: Application
    Filed: July 26, 2011
    Publication date: February 2, 2012
    Applicant: BASF SE
    Inventors: Raimund Schmid, Ellen Schmidt